CompletedNCT03558074
Evaluate the Therapeutic Effects and Safety of ALK4290 in Patients With Refractory Wet Age-Related Macular Degeneration
PHASE2 · 26 planned enrolment
- Countries listed
- 1
- Registry update
- December 22, 2020
Source-linked trial list
The registrations behind this number.
Verify the exact trial registrations behind a company, intervention, programme or topic count.
Exact trial list
2 matching trial registrations
- Intervention ALK4290
Showing 1–2 of 2. Every record below meets all the filters shown above.
CompletedNCT03558061
Evaluate the Effects and Safety of ALK4290 in Patients With Newly Diagnosed Wet Age-Related Macular Degeneration
PHASE2 · 30 planned enrolment
- Countries listed
- 1
- Registry update
- December 16, 2020